1-2 of 2
Joern Starklint
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Genomic Profiling of a Phase III Clinical Trial of Interferon Versus Hydroxyurea in MPN Patients Reveals Mutation-Specific and Treatment-Specific Patterns of Response

Trine Alma Knudsen, MD, Vibe Skov, PhD, Lillian Werner, MS, William Duke, Christopher J. Gibson, MD, Anwesha Nag, PhD, Aaron R. Thorner, PhD, Bruce Wollison, MS, Dennis Lund Hansen, MD, Thomas Stauffer Larsen, MD PhD, Christina Ellervik, MD PhD, Daniel El Fassi, MD, Karin de Stricker, MD, Lukas Frans Ocias, MD, Mette Brabrand, Ole Weis Bjerrum, MD PhD, Ulrik Malthe Overgaard, MD, Mikael Frederiksen, MD, Thomas Kielsgaard Kristensen, Torben A Kruse, Mads Thomassen, PhD, Torben Mourits-Andersen, MD, Marianne Tang Severinsen, MD PhD, Jesper Stentoft, MD, Joern Starklint, Peter Møller, MD, Donna S Neuberg, ScD, Lasse Kjær, PhD, Hans Hasselbalch, MD, R. Coleman Lindsley, MD PhD, Ann Mullally, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4202.
https://doi.org/10.1182/blood-2019-126164
Published: 2019
Journal Articles

Lymphoma Patients Treated without Anthracyclines Have Negligible Risk of Cardiotoxicity: A Nationwide Cohort Study

Joachim Baech, Steen Moeller Hansen, Peter Enemark Lund, Christian Torp-Pedersen, Peter Soegaard, Peter de Nully Brown, MD PhD, Henrik Frederiksen, Judit Mészáros Jørgensen, Joern Starklint, Pär Josefsson, MD PhD, Christian Bjørn Poulsen, Hans Erik Johnsen, MD Professor, Tarec Christoffer El-Galaly, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2843.
https://doi.org/10.1182/blood.V130.Suppl_1.2843.2843
Published: 2017